TGFB1 and neoplasm: Several different molecules and signaling pathways have been described that may be involved in the induction of the tolerogenic and immunosuppressive properties of tumor-associated DCs, including production of IL-10 and TGF-β; expression of IDO, iNOS and arginase: or expression of inhibitory B7-related molecules [104,105].